Chronic Myeloproliferative Disorders Terminated Phase 2 Trials for Thiotepa (DB04572)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00066417Peripheral Stem Cell Transplant in Treating Patients With High-Risk LeukemiaTreatment